— Know what they know.
Not Investment Advice

KURA NASDAQ

Kura Oncology, Inc.
1W: +14.3% 1M: +16.8% 3M: +31.6% YTD: +7.6% 1Y: +74.5% 3Y: -11.1% 5Y: -55.7%
$11.25
+0.12 (+1.08%)
 
Weekly Expected Move ±5.7%
$8 $9 $9 $10 $10
NASDAQ · Healthcare · Biotechnology · Alpha Radar Buy · Power 62 · $998.7M mcap · 86M float · 1.74% daily turnover · Short 33% of daily vol

📊 Key Metrics

TTM
$72M
Revenue
+5.4% YoY
$-295M
Net Income
-62.0% YoY
$-84M
Free Cash Flow
-176.4% YoY
96.6%
Gross Margin
-431.5%
Op. Margin
-401.5%
Net Margin

💰 Income Flow

How revenue becomes profit

💵 Cash Flow

⚠️ Cash Burn Where cash goes

🏦 Balance Sheet

Assets = Liabilities + Equity

📈 Financial Health

Profitability

ROE-100.2%
ROA-39.3%
ROIC53.1%

Valuation

P/E-3.4
P/B9.3
EV/EBITDA-0.2

Leverage

Debt/Equity0.12
Current Ratio6.06
Interest Cov.-278.9x

Quality Scores

Piotroski F2/9
Altman Z-1.74
Beneish M-3.22

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms